Dose fractionation, dose rate and iso-effect relationships for normal tissue responses.
about
Modern Radiotherapy Concepts and the Impact of Radiation on Immune ActivationHybrid Imaging for Patient-Specific Dosimetry in Radionuclide TherapyTreatment of Breast and Prostate Cancer by Hypofractionated Radiotherapy: Potential Risks and BenefitsCancer concepts and principles: primer for the interventional oncologist-part IIRadiotherapy and the tumor stroma: the importance of dose and fractionationChallenges in radiobiological modeling: can we decide between LQ and LQ-L models based on reviewed clinical NSCLC treatment outcome data?Estimating dose painting effects in radiotherapy: a mathematical modelTowards multidimensional radiotherapy: key challenges for treatment individualisation.MRS-guided HDR brachytherapy boost to the dominant intraprostatic lesion in high risk localised prostate cancer.Clinicopathologic features and responses to radiotherapy of myeloid sarcoma.Improved survival of mice after total body irradiation with 10 MV photon, 2400 MU/min SRS beam.Seven fractions to deliver partial breast irradiation: the toxicity is LowThe impact of PET/CT scanning on the size of target volumes, radiation exposure of organs at risk, TCP and NTCP, in the radiotherapy planning of non-small cell lung cancer.Estimating functional liver reserve following hepatic irradiation: adaptive normal tissue response modelsLow-dose strontium-90 irradiation is effective in preventing the recurrence of pterygia: a ten-year study.Concurrent chemoradiotherapy with tomotherapy in locally advanced Non-Small Cell Lung Cancer: a phase I, docetaxel dose-escalation study, with hypofractionated radiation regimenAdjuvant chemotherapy and acute toxicity in hypofractionated radiotherapy for early breast cancerComparison of RBE values of high-LET α-particles for the induction of DNA-DSBs, chromosome aberrations and cell reproductive death.Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option.Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysisIncreased Biological Effective Dose of Radiation Correlates with Prolonged Survival of Patients with Limited-Stage Small Cell Lung Cancer: A Systematic Review.Development and dosimetry of a small animal lung irradiation platform.Application of radiobiological dosimetry to radionuclide directed therapy.Radiation-induced damage in the central nervous system: an interpretation of target cell responses.Effect of dose per fraction on the division potential of lethally irradiated plateau-phase CHO cells exposed to isoeffective fractionation regimens21 years of biologically effective doseModelling the correlation between EGFr expression and tumour cell radiosensitivity, and combined treatments of radiation and monoclonal antibody EGFr inhibitors.Biological modelling of the radiation dose escalation effect of regional hyperthermia in cervical cancerComparison of breast sequential and simultaneous integrated boost using the biologically effective dose volume histogram (BEDVH)Treatment of squamous cell carcinoma of the uterine cervix with radiation therapy alone: long-term survival, late complications, and incidence of second cancers.Exploring two two-edged swords.Emesis as a Screening Diagnostic for Low Dose Rate (LDR) Total Body Radiation ExposurePrediction of liver function by using magnetic resonance-based portal venous perfusion imagingStereotactic body radiotherapy for lesions of the spine and paraspinal regionsThree-dimensional imaging-based radiobiological dosimetry.Predictive models for regional hepatic function based on 99mTc-IDA SPECT and local radiation dose for physiologic adaptive radiation therapyIonizing radiation, ion transports, and radioresistance of cancer cellsHyperfractionation of HDR brachytherapy - influence on doses and biologically equivalent doses in clinical target volume and healthy tissues.Influence of length of interval between pulses in PDR brachytherapy (PDRBT) on value of Biologically Equivalent Dose (BED) in healthy tissues.Aortic dose constraints when reirradiating thoracic tumors.
P2860
Q26744490-A628DB26-7195-47CD-B712-A09694AAC6D9Q26768478-BF35CB1D-658C-42DC-9E88-8E32C4FEC6D5Q26998991-9752372D-F420-44FB-B84E-4EF745DE6F9EQ27010961-640AF9EA-EED7-4813-84ED-D9A0CF1F3784Q27022685-FED09C3C-62DB-4F8D-8106-78715517F773Q27301421-83C9EFA4-DE19-440A-9098-DABD9FED3458Q27321048-BDA58423-57DD-467D-8E57-9E3560AB07F6Q27687218-E81BA969-F257-4C7A-889E-3F80A96315FAQ30988899-387F30DF-185A-4F0A-90AF-7861D3670C16Q33592357-E8F62E42-3DBB-4BFB-BD33-077318C27220Q33713405-F58D6CAC-E7FF-44A0-B999-932CE2B3360DQ33721910-4E42646E-02EC-45A0-9FAC-ADA12CEABF5CQ33760747-3A2CD750-CF10-4CB1-BD6B-52991A387E92Q33992068-CDFCF95F-114E-4DF5-88AF-9CB092E17E50Q34405240-4D281CA4-8ED4-436E-B4A0-EB7ECB54E956Q34493493-781F3ED3-DD43-4AA6-BF05-27D2651F39BEQ34520010-C140B06B-5A95-4228-8F56-9F2038ABFCD7Q35081208-CE5CE72A-8716-40FC-8F77-88CC56C8F80DQ35678065-EEFDE0F9-FED0-46F9-9A87-109D4B57A059Q35803550-7EF5A68C-9677-44B7-82A4-35A622902504Q36030323-422A4DB5-8846-4D8B-A8E4-57E98A29DF3EQ36191131-45944202-7478-4CDE-9614-5743056108D2Q36290951-1598133E-5F4E-4390-AC79-7A7AB745AC09Q36291381-47E4039F-DEE4-400F-B780-AB239DCB12B7Q36291437-499498FD-DBCC-4A0B-8596-BF249AA01672Q36324701-4EB66809-F0C4-4C41-9D42-FAE7573582D3Q36412543-708E868A-29A4-4F45-8496-1C3D592DDC4FQ36529015-4922C608-0DB8-44D1-85A4-3E7CBE32D8C6Q36529659-41769CBC-DA8E-4A2F-8BD3-43E3CCF7D328Q36611376-7E76E96E-32F6-4336-9791-C661E57CB670Q36611916-5A285264-D832-4DE9-8AE9-C196372C24D9Q36628984-F62F13B5-187F-488C-9F5F-18C7B5709292Q36775688-67A8D7C2-9CDB-40DF-B52F-310B744A9B38Q36915978-7DC6BA0F-5E96-4D35-8665-F03556640CEEQ37002485-D2975B89-DEFF-483A-8333-7C5D944992D2Q37009671-3FEEBD8C-77FE-41AA-9103-2AAE65B80CE5Q37095176-AC814378-28C1-4234-8935-8B67621D4288Q37360571-566D53EC-752B-45AF-8581-02ACCADA81BFQ37393281-DBDDB0F9-1604-4AB6-B9EC-0CFCDC14D3C2Q37579456-C294AECF-4756-4A0A-9FBE-40452437BB9D
P2860
Dose fractionation, dose rate and iso-effect relationships for normal tissue responses.
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
1982年论文
@zh
1982年论文
@zh-cn
name
Dose fractionation, dose rate and iso-effect relationships for normal tissue responses.
@en
type
label
Dose fractionation, dose rate and iso-effect relationships for normal tissue responses.
@en
prefLabel
Dose fractionation, dose rate and iso-effect relationships for normal tissue responses.
@en
P1476
Dose fractionation, dose rate and iso-effect relationships for normal tissue responses
@en
P2093
G W Barendsen
P304
P356
10.1016/0360-3016(82)90459-X
P407
P577
1982-11-01T00:00:00Z